Twist Bioscience touts 4 day gene synthesis and multiplexed panels for Pi Day

Twist Bioscience touts 4 day gene synthesis and multiplexed panels for Pi Day
Twist Bioscience touts rapid gene synthesis

Twist Bioscience celebrates Pi Day by highlighting its rapid gene synthesis capabilities and advanced technologies.

The company outlines the ability to express genes in as fast as 4 days for sequences ranging from 0.3 to 5 kb, distribute multiplexed gene fragments at 500 base pairs, and provide next generation sequencing (NGS) panels with over 1 million probes per pool. As genetic research and synthetic biology expand, speed and scalability in DNA synthesis remain key differentiators for industry leaders like Twist Bioscience.

Twist Bioscience’s continued advancements in rapid gene synthesis underscore the company’s broader ambitions within synthetic biology. Recent developments, including efforts to harness engineered immune cell technology for potential type 1 diabetes treatment, as explored in the context of engineered immune cells, highlight the expanding intersections of genetic research and therapeutics. Meanwhile, the acceleration of DNA synthesis also brings attention to emerging biosecurity challenges, such as the use of AI to create synthetic homologs that can bypass established screening systems—an issue at the forefront of ongoing industry discussions, as reported in the analysis of AI-driven biosecurity concerns.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.